Legal & General Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.4K | Buy |
5,836
+1,439
| +33% | +$5.51K | ﹤0.01% | 2962 |
|
|
2025
Q1 | $25.3K | Hold |
4,397
| – | – | ﹤0.01% | 2863 |
|
|
2024
Q4 | $21.9K | Hold |
4,397
| – | – | ﹤0.01% | 2986 |
|
|
2024
Q3 | $23.7K | Buy |
4,397
+280
| +7% | +$1.51K | ﹤0.01% | 2984 |
|
|
2024
Q2 | $13.6K | Sell |
4,117
-1,010
| -20% | -$3.34K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $16.7K | Sell |
5,127
-4,213
| -45% | -$13.8K | ﹤0.01% | 3037 |
|
|
2023
Q4 | $32.8K | Sell |
9,340
-28,254
| -75% | -$99.2K | ﹤0.01% | 2880 |
|
|
2023
Q3 | $251K | Sell |
37,594
-303
| -0.8% | -$2.03K | ﹤0.01% | 2669 |
|
|
2023
Q2 | $318K | Buy |
+37,897
| New | +$318K | ﹤0.01% | 2614 |
|
|
2022
Q2 | – | Sell |
-5,289
| Closed | -$24K | – | 3518 |
|
|
2022
Q1 | $24K | Buy |
5,289
+307
| +6% | +$1.39K | ﹤0.01% | 3182 |
|
|
2021
Q4 | $20K | Sell |
4,982
-150
| -3% | -$602 | ﹤0.01% | 3275 |
|
|
2021
Q3 | $45K | Hold |
5,132
| – | – | ﹤0.01% | 3002 |
|
|
2021
Q2 | $58K | Buy |
+5,132
| New | +$58K | ﹤0.01% | 2903 |
|
|
2020
Q2 | – | Sell |
-3,904
| Closed | -$10K | – | 3410 |
|
|
2020
Q1 | $10K | Hold |
3,904
| – | – | ﹤0.01% | 3148 |
|
|
2019
Q4 | $23K | Buy |
3,904
+622
| +19% | +$3.66K | ﹤0.01% | 3140 |
|
|
2019
Q3 | $17K | Hold |
3,282
| – | – | ﹤0.01% | 3180 |
|
|
2019
Q2 | $20K | Hold |
3,282
| – | – | ﹤0.01% | 3189 |
|
|
2019
Q1 | $30K | Hold |
3,282
| – | – | ﹤0.01% | 2925 |
|
|
2018
Q4 | $27K | Buy |
3,282
+922
| +39% | +$7.59K | ﹤0.01% | 2948 |
|
|
2018
Q3 | $33K | Hold |
2,360
| – | – | ﹤0.01% | 2976 |
|
|
2018
Q2 | $19K | Buy |
+2,360
| New | +$19K | ﹤0.01% | 3198 |
|